We are MMCORC, a #NCORP of 22 community hospitals and oncology clinics with over 250 providers offering #ClinicalTrials to people in their own communities.

MN and Western WI
Joined February 2022
Sharing with you @NRGonc communication that takes community members behind the scenes of research process and results > including SUMMARY OF RESULTS FOR PATIENTS section.
NRG Oncology Weekly Broadcast for October 19, 2026: conta.cc/4A26umD
3
Metro-MN Community Oncology Research Consortium retweeted
NRG Oncology is currently accepting applications for travel awards to #NRG2027 in Las Vegas! Application window closes November 9th. More information can be found at ow.ly/oJEj50ZZ617
2
1
242
792 locations, including @MMCORC! A022102 is studying mFOLFIRINOX vs mFOLFOX with or without immunotherapy drug nivolumab for metastatic HER2 negative esophageal, gastroesophageal junction and gastric cancer. More: bit.ly/Alliance-A022102 #ColorectalCancer #clinicaltrials
1
95
MMCORC @AllinaHealth Research Day 2026 - sharing a day of innovation and celebration! Together we provide over 100 clinical trial options to the community and have a research team ready to help.
9
Major HER2+ breast cancer trial identifies factors associated with pathologic complete response to less intensive chemotherapy ecog-acrin.org/press-release…
1
54
1
2
38
Metro-MN Community Oncology Research Consortium retweeted
October is #BreastCancerAwarenessMonth. Clinical trial research plays a critical role in improving cancer care. We remain committed to advancing clinical trials that help answer important ?s and brings new knowledge to patients & the cancer community. ow.ly/N9n150ZQkrp
2
1
308
Protocol Activation @MMCORC! NRG-CC017: A randomized phase III study comparing temporally-modulated pulsed radiation therapy (TMPRT) versus standard radiation therapy with temozolomide for adults with newly diagnosed MGMT-unmethylated glioblastoma conta.cc/3PKI3bl
2
50
Now Available @MMCORC > A012303 (ShortStop-HER2), a study testing if less treatment after surgery is an option for people with early-stage HER2+ #breastcancer who had no cancer left after chemo + HER2 therapy. bit.ly/Alliance-A012303
28
Open study at mmcorc.org/locations, A052101, a trial to see if older people with mantle cell lymphoma can receive fewer treatments of the targeted cancer medicine zanubrutinib while in remission.
38
Locally, you can enroll to Dr. Ugonma Chukwueke's @ALLIANCE_org trial exploring if adding a targeted medicine called vorasidenib to the usual treatment can help people with newly diagnosed IDH mutated grade 3 astrocytoma, a type of brain cancer. bit.ly/Brain2026
1
3
55
Metro-MN Community Oncology Research Consortium retweeted
For #ProstateCancerAwarenessMonth we take a look at several NRG prostate trials that recently completed accrual. Read the article from our September newsletter: nrgoncology.org/Home/News/Po…
2
2
304
Metro-MN Community Oncology Research Consortium retweeted
For #Gynecologic and #Ovarian #Cancer Month - we spotlight some updates on currently enrolling NRG gynecologic studies in our September newsletter. Read the article: ow.ly/Cgov50ZNW5x
3
1
293
September is #ProstateCancerAwarenessMonth! 💙From precision diagnostics and targeted therapies to telehealth exercise programs, @ALLIANCE_org clinical trials are driving the next generation of cancer care. Local access to current trials at mmcorc.org/gu/
1
112
OPEN to ENROLLMENT @ mmcorc.org/locations > a study that compares the effect of adding chemo to immunotherapy (pembrolizumab) versus immunotherapy alone in treating patients with stage IIIB-IV lung #LungCancer - the ACHIEVE Trial!
44
Metro-MN Community Oncology Research Consortium retweeted
Reaching a target long thought "undruggable,” a new RAS inhibitor nearly doubled survival in metastatic pancreatic cancer. What once seemed impossible is giving new hope to countless families. Tell Congress to protect research funding: bit.ly/4qMQYYg #ASCOAdvocacy
2
6
15
3,768
Metro-MN Community Oncology Research Consortium retweeted
Have you noticed that we like to feature the @fortestudy in our social posts on Fridays? Check out the latest about this #colorectalcancer prevention study in the August edition of our newsletter ↪️ ow.ly/c7kB50ZytZg
2
3
346